PSEUDOCHOLINESTERASE AS A PREDICTOR MARKER IN HYPOTHYROID PATIENTS

Main Article Content

Kaushik GG
Soni Reena

Abstract

Introduction: Hypothyroidism is due to decreased circulating levels of Thyroid hormones and is caused by inadequate functioning of thyroid gland. Pseudocholinesterase (PCHE) is a nonspecific cholinesterase enzyme that hydrolyses choline based esters in plasma. The purpose of this study was to evaluate the serum level of PCHE in hypothyroid patients. Methodology: The present study was conducted on 100 newly diagnosed hypothyroid patients attending the Medical OPD. The results of patients were compared with 100 healthy controls of either sex of similar age group. Anthropometric measurements, T3, T4, TSH, PCHE & Cholesterol estimations were performed. Results: The mean serum PCHE (decrease) level was observed statistically highly significant (p<0.001) in hypothyroid patients as compared with healthy control subjects.  A highly significant positive correlation between PCHE with T3 & T4 (p< 0.001) in hypothyroid cases. Conclusion: Serum Pseudocholinesterase may be helpful as biomarker in screening test  for hypothyroidism along with thyroid stimulating hormone.

Article Details

How to Cite
GG, K., & Reena, S. (2018). PSEUDOCHOLINESTERASE AS A PREDICTOR MARKER IN HYPOTHYROID PATIENTS. International Journal of Clinical and Biomedical Research, 4(3), 27-29. https://doi.org/10.31878/ijcbr.2018.43.06
Section
Original Research Articles

References

1. Kochupillai N. Clinical endocrinology in India. Current Science. 2000;79:1061-1067.
2. Thompson JC, Whittaker M. Pseudocholinesterase activity in thyroid disease. J. Clin. Path. 1965;18:811
3. Porter WH. Carl AB, Edward RA editors, Tietz Textbook of clinical chemistry. Clinical Toxicology. 3rd edition, Elsevier Health Sciences. 1999;940.
4. Vlaicu R, Popescu E, Popescu TA, Cucuianu M. Serum electrophoretic lipoprotein factors and pseudocholinesterase activity in thyroid disease.Endocrinologie. 1978;16(2):147-51.
5. Sleeba SK, Prasad BNR, Bangera M. Pseudocholinesterase as a biochemical marker in hypothyroidism. Asian J Pharm Clin Res. 2013;16(2):9-20.
6. WHO expert consultation. Appropriate body-mass index for Asian populations and its implications for policy and intervention strategies. The Lancet, 2004; 157-163.
7. Hollander CS. Clinical laboratory observation in cases of T3 toxicosis confirmed by radioimmunoassay. Lancet.1972;1:609-611.
8. Schuurs AHWM and Van Weeman BK. Review Enzyme immunoassay. Clin. Chem. Acta.1977; 81:1
9. Uotila M, Ruoslahti E and Engvall E. J. Immunol. Methods. 1981;42:11-15.
10. Charles h. Sawyer and John W. Everett. Liver synthesis of serum cholinesterase. Am j physiol. 1947;148(3):67583.
11. Allian CC, Poon LS, Chan CSG, Richmond W and Fu P: Enzymatic determination of total serum cholesterol. Clin. Chem 1974; 20: 470.
12. Thompson J.C and Whittakker M. Pseudocholinesterase activity in thyroid disease. J. clin. Path, 1965; 18, 811.